https://nl.marketscreener.com/koers/aandeel/REGULUS-THERAPEUTICS-INC-46475580/nieuws/Regulus-Therapeutics-gaat-door-naar-cohort-4-van-de-Fase-1B-Multiple-Ascending-Dose-klinische-studie-46645500/?utm_source=telegram&utm_medium=social&utm_campaign=share